Food Allergies: Biologics Bring Hope (AAN)
Price: FREE for members and non-members
Session recorded on May 10, 2023
Speaker: Lindsey Moore, DO, FACAAI, FAAP
Despite robust advancements in available treatment options for allergic diseases, options for food allergy treatment remain scarce. This discussion may help set the stage for a shared decision making approach in selecting various biologic medications for their patients. Topcis to be discussed include utilizing appropriate treatment strategies for patients with food allergy and how biologics treating atopic diseases may impact the treatment of food allergies.
Viewers can earn credit by completing the posttest questions.
This program is a collaboration between the American College of Allergy, Asthma & Immunology and the Allergy and Asthma Network.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Primary Care Providers
Pediatricians
Fellows-in-Training
Allied Health Professionals
Learning Objectives
Upon completion of this activity, learners should be able to:
1. Review current management options for food allergy and identify limitations of this approach
2. Discuss the therapeutic potential of biologics for food allergy
All relevant financial relationships have been mitigated.
The individuals listed below disclose the following financial relationships:
Lindsey Moore, DO
Speaker: Aimmune
Independent Contractor: Kenota
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance